The FDA has recently approved the French emergency contraceptive drug (ella) for clinical use in the United States. In an earlier blog post, we expressed our objection. The new drug is actually chemically related to the abortion drug RU-486 (mifepristone), and it has a high likelihood acting as an abortifacient. In other words, the drug may act to prevent pregnancy, not just by preventing ovulation, but by aborting a new life.
In this podcast, our guest is Dr. Jeff Lewis, Assistant Dean of the School of Pharmacy at Cedarville University.